lncRNA targets the enhancer region and positively regulates the gene expression. |
Only predicted by TDF | IWS1,N6AMT1,SLX4,DCAF16,RUSF1,ACVR2B,DHX57,RBM33,HCFC1,TRMT13,ERI2,IFT140,HEXIM2,RNF40,CEP290,OSGEPL1,RBM41,PROSER3,XPO1,COG7,SRRM2,SH2B1,CCDC142,NKTR,SLC24A1,CRAMP1,SETD5,ZFP62,MBTD1,GON4L,IQCE,POGZ,ATXN2L,UBFD1,NFRKB,SRCAP,BRD8,ZNF91,SMG1,DIDO1,EPM2AIP1,MAPK8IP3,ARIH2,KAT8,INTS3,SUGP2,CCAR1,YTHDC1,DDX42,DGKD,ZDHHC23,FAM193A,TIGD1,UNKL,GSK3B,ADNP,TRIM52,MYEF2,HECTD4,TEFM,SPIN3,ARID4B,PALB2,RBM28,PRPF40B,FUBP1,DCAF8,KHDC4,STK36,METTL6,KATNIP,SMARCC1,DCAF17,FBRS,TSC1,GSTCD,TET3,ZNF720,HEMK1,CCDC191,RABL2A,INCA1,KCTD13,GTF3C2,CCDC40,DNMT3A,DCAF1,TRMT10A,NR2C2,PAN2 | Exist in public source | NA |
lncRNA targets the promoter region and positively regulates the gene expression. |
lncRNA targets the promoter region and negatively regulates the gene expression. |
lncRNA targets the 3'UTR region and negatively regulates the mRNA. |
lncRNA targets the skipped exon region. | -lncRNA and exonskipping events are positively correlated. |
LncRNA Ensembl ID | LncRNA ENST ID | Exon ID | Skipped Exon | dG | ndG | Gene name with skipped exon | TransID with skipped exon | ORF mutation |
-lncRNA and exonskipping events are negatively correlated. |
LncRNA Ensembl ID | LncRNA ENST ID | Exon ID | Skipped Exon | dG | ndG | Gene name with skipped exon | TransID with skipped exon | LOF |
lncRNA targets by miRNA. |
LncRNA Ensembl ID | miRNA ID | LncRNA ENST ID | Binding site in lncRNA | Score | Energy | Align Len | Public source |
RNA A-to-I editing events in lncRNA. |
LncRNAediting ID | LncRNA Ensembl ID | Chromosome | Editing Position | Strand | Gene Type | Gene Name | Transcript ID | Transcript Type | Transcript Name | LncEditing_308337 | ENSG00000260852.1 | chr16 | 30920355 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308347 | ENSG00000260852.1 | chr16 | 30920419 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308349 | ENSG00000260852.1 | chr16 | 30920424 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308350 | ENSG00000260852.1 | chr16 | 30920425 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308353 | ENSG00000260852.1 | chr16 | 30920434 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308354 | ENSG00000260852.1 | chr16 | 30920435 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308362 | ENSG00000260852.1 | chr16 | 30920482 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308364 | ENSG00000260852.1 | chr16 | 30920488 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308365 | ENSG00000260852.1 | chr16 | 30920489 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308366 | ENSG00000260852.1 | chr16 | 30920491 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308380 | ENSG00000260852.1 | chr16 | 30920695 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308385 | ENSG00000260852.1 | chr16 | 30920758 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308389 | ENSG00000260852.1 | chr16 | 30920797 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308397 | ENSG00000260852.1 | chr16 | 30921378 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308407 | ENSG00000260852.1 | chr16 | 30921487 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308410 | ENSG00000260852.1 | chr16 | 30921508 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 | LncEditing_308411 | ENSG00000260852.1 | chr16 | 30921518 | - | antisense | FBXL19-AS1 | ENST00000563777.1 | antisense | FBXL19-AS1-001 |
Edited-associated DElncRNAs in cancer. |
|
LncRNA Ensembl ID | LncRNA Index | Cancer Type | Chr_Postion_Strand | AVE1 | AVE2 | log2FC | W-value | P-value | Adjc.p-value | Change | ENSG00000260852 | LncEditing_308337 | LAML | chr16_30920355_- | 6.724848e+00 | 4.457919e+00 | 1.685968e+00 | 3.856177e+00 | 1.151743e-04 | 1.798234e-04 | UP | ENSG00000260852 | LncEditing_308347 | LAML | chr16_30920419_- | 7.604550e+00 | 4.526158e+00 | 1.335870e+00 | 5.017668e+00 | 5.230236e-07 | 1.279078e-06 | UP | ENSG00000260852 | LncEditing_308349 | LAML | chr16_30920424_- | 6.482877e+00 | 3.821309e+00 | 1.311359e+00 | 6.454412e+00 | 1.086397e-10 | 6.419620e-10 | UP | ENSG00000260852 | LncEditing_308350 | LAML | chr16_30920425_- | 6.257788e+00 | 5.050621e+00 | 3.234234e+00 | 2.853540e+00 | 4.323510e-03 | 5.042053e-03 | UP | ENSG00000260852 | LncEditing_308353 | LAML | chr16_30920434_- | 6.009626e+00 | 4.946108e+00 | 3.558955e+00 | 3.602142e+00 | 3.156057e-04 | 4.495653e-04 | UP | ENSG00000260852 | LncEditing_308354 | LAML | chr16_30920435_- | 5.914361e+00 | 3.204359e+00 | 1.130983e+00 | 6.535241e+00 | 6.350732e-11 | 3.982220e-10 | UP | ENSG00000260852 | LncEditing_308362 | LAML | chr16_30920482_- | 8.342730e+00 | 4.695449e+00 | 1.205899e+00 | 3.798606e+00 | 1.455121e-04 | 2.218610e-04 | UP | ENSG00000260852 | LncEditing_308364 | LAML | chr16_30920488_- | 7.096874e+00 | 4.141062e+00 | 1.286698e+00 | 6.409434e+00 | 1.460610e-10 | 8.312689e-10 | UP | ENSG00000260852 | LncEditing_308365 | LAML | chr16_30920489_- | 7.272964e+00 | 4.141685e+00 | 1.231033e+00 | 6.678098e+00 | 2.420631e-11 | 1.738069e-10 | UP | ENSG00000260852 | LncEditing_308366 | LAML | chr16_30920491_- | 7.193018e+00 | 4.295996e+00 | 1.344801e+00 | 5.926922e+00 | 3.086649e-09 | 1.258090e-08 | UP | ENSG00000260852 | LncEditing_308380 | LAML | chr16_30920695_- | 6.711496e+00 | 3.781401e+00 | 1.208147e+00 | 7.201466e+00 | 5.956877e-13 | 6.627696e-12 | UP | ENSG00000260852 | LncEditing_308389 | LAML | chr16_30920797_- | 8.029806e+00 | 4.500771e+00 | 1.197328e+00 | 5.356770e+00 | 8.472303e-08 | 2.467758e-07 | UP | ENSG00000260852 | LncEditing_308397 | LAML | chr16_30921378_- | 7.369121e+00 | 4.362040e+00 | 1.321896e+00 | 5.476716e+00 | 4.332923e-08 | 1.327831e-07 | UP | ENSG00000260852 | LncEditing_308407 | LAML | chr16_30921487_- | 7.973004e+00 | 4.650443e+00 | 1.285751e+00 | 4.346295e+00 | 1.384562e-05 | 2.540764e-05 | UP | ENSG00000260852 | LncEditing_308410 | LAML | chr16_30921508_- | 7.413434e+00 | 4.104903e+00 | 1.172616e+00 | 7.173778e+00 | 7.295609e-13 | 7.973519e-12 | UP | ENSG00000260852 | LncEditing_308411 | LAML | chr16_30921518_- | 6.894849e+00 | 3.982896e+00 | 1.263103e+00 | 6.615578e+00 | 3.701029e-11 | 2.484115e-10 | UP | ENSG00000260852 | LncEditing_308354 | KIRP | chr16_30920435_- | 2.319876e+00 | 1.033514e+00 | 8.572724e-01 | 8.671487e+00 | 4.265125e-18 | 2.659779e-17 | UP | ENSG00000260852 | LncEditing_308349 | CHOL | chr16_30920424_- | 2.411237e+00 | 1.183882e+00 | 9.744235e-01 | 2.567172e+00 | 1.025318e-02 | 1.594939e-02 | UP | ENSG00000260852 | LncEditing_308353 | CHOL | chr16_30920434_- | 2.573931e+00 | 1.163546e+00 | 8.730228e-01 | 2.667845e+00 | 7.633939e-03 | 1.350002e-02 | UP | ENSG00000260852 | LncEditing_308354 | CHOL | chr16_30920435_- | 2.573931e+00 | 1.163546e+00 | 8.730228e-01 | 2.667845e+00 | 7.633939e-03 | 1.350002e-02 | UP | ENSG00000260852 | LncEditing_308389 | CHOL | chr16_30920797_- | 2.484694e+00 | 1.132442e+00 | 8.821212e-01 | 2.675961e+00 | 7.451532e-03 | 1.350002e-02 | UP | ENSG00000260852 | LncEditing_308337 | OV | chr16_30920355_- | 2.084286e+00 | 9.508190e-01 | 8.831500e-01 | 9.130771e+00 | 6.801302e-20 | 3.088295e-19 | UP | ENSG00000260852 | LncEditing_308347 | OV | chr16_30920419_- | 2.101368e+00 | 1.072258e+00 | 1.030209e+00 | 6.203886e+00 | 5.508557e-10 | 9.405976e-10 | UP | ENSG00000260852 | LncEditing_308349 | OV | chr16_30920424_- | 2.024950e+00 | 8.743709e-01 | 8.253758e-01 | 1.073818e+01 | 6.736056e-27 | 5.788601e-26 | UP | ENSG00000260852 | LncEditing_308353 | OV | chr16_30920434_- | 2.269960e+00 | 1.016550e+00 | 8.628234e-01 | 8.033312e+00 | 9.487564e-16 | 2.814134e-15 | UP | ENSG00000260852 | LncEditing_308362 | OV | chr16_30920482_- | 2.306494e+00 | 1.041893e+00 | 8.722242e-01 | 7.428180e+00 | 1.101017e-13 | 2.692514e-13 | UP | ENSG00000260852 | LncEditing_308385 | BRCA | chr16_30920758_- | 2.951500e+00 | 1.300463e+00 | 8.457207e-01 | 1.364314e+01 | 2.217995e-42 | 6.528270e-42 | UP | ENSG00000260852 | LncEditing_308347 | ESCA | chr16_30920419_- | 2.028812e+00 | 8.839932e-01 | 8.343566e-01 | 6.219525e+00 | 4.986625e-10 | 1.402949e-09 | UP |
Correlation between RNA A-to-I editing events's frequecy and lncRNA expression. |
LncRNA Ensembl ID | LncRNA Index | Correlation | P-value | Adjc.p-value | ENSG00000260852 | LncEditing_308347 | -3.642608e-01 | 2.455618e-02 | 2.599362e-02 | ENSG00000260852 | LncEditing_308353 | -3.610153e-01 | 1.170518e-02 | 1.395617e-02 | ENSG00000260852 | LncEditing_308389 | -3.220071e-01 | 1.461624e-03 | 2.699339e-03 | ENSG00000260852 | LncEditing_308337 | -5.086947e-01 | 1.534897e-03 | 7.089761e-03 | ENSG00000260852 | LncEditing_308349 | -3.728448e-01 | 8.329257e-03 | 1.801401e-02 | ENSG00000260852 | LncEditing_308353 | -5.621311e-01 | 2.800716e-03 | 9.749391e-03 | ENSG00000260852 | LncEditing_308354 | -3.230963e-01 | 1.717178e-02 | 2.660803e-02 | ENSG00000260852 | LncEditing_308362 | -4.531521e-01 | 2.989165e-02 | 3.698330e-02 | ENSG00000260852 | LncEditing_308389 | -3.825136e-01 | 2.802328e-02 | 3.587450e-02 | ENSG00000260852 | LncEditing_308407 | -7.631380e-01 | 3.613912e-05 | 2.780145e-03 | ENSG00000260852 | LncEditing_308347 | -3.533705e-01 | 4.725955e-02 | 4.842852e-02 | ENSG00000260852 | LncEditing_308353 | -5.464843e-01 | 1.000689e-03 | 7.531232e-03 | ENSG00000260852 | LncEditing_308362 | -6.994842e-01 | 5.979839e-04 | 5.594043e-03 | ENSG00000260852 | LncEditing_308407 | -4.073982e-01 | 4.815819e-02 | 4.883174e-02 | ENSG00000260852 | LncEditing_308337 | 3.300544e-01 | 4.930798e-02 | 4.930798e-02 | ENSG00000260852 | LncEditing_308354 | 3.287420e-01 | 1.975542e-02 | 2.341364e-02 |
Cis-expression quantitative trait loci(cis-eQTL) of lncRNA. |
LncRNA Ensembl ID | LncRNA Name | SNP info | Number of Positive corelated Cancer | Positive corelated Cancer | Number of Negative corelated Cancer | Negative corelated Cancer |
lncRNA regulates differentially expressed genes by function as enhancer. |
LncRNA Ensembl ID | PC Gene ID | PC Gene Name | Positive correlated cancers | Cancer with PC gene up-regulation | Cancer with PC gene down-regulation | ENSG00000260852 | ENSG00000007545 | CRAMP1 | BRCA,CHOL,KIRP,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000047578 | KATNIP | BRCA,CHOL,ESCA,KIRP,OV,PRAD,UCS | CHOL | | ENSG00000260852 | ENSG00000106012 | IQCE | BRCA,CHOL,ESCA,KIRP,OV | CHOL | | ENSG00000260852 | ENSG00000116580 | GON4L | BRCA,CHOL,KIRP,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000132680 | KHDC4 | BRCA,CHOL,KIRP,LUAD,PRAD | CHOL,LUAD | | ENSG00000260852 | ENSG00000138780 | GSTCD | BRCA,CHOL,ESCA,LAML,UCS | CHOL | | ENSG00000260852 | ENSG00000138834 | MAPK8IP3 | BRCA,CHOL,KIRP,OV,UCS | CHOL,KIRP | | ENSG00000260852 | ENSG00000141519 | CCDC40 | BRCA,CHOL,KIRP,OV,PRAD | CHOL,KIRP | | ENSG00000260852 | ENSG00000163482 | STK36 | BRCA,CHOL,ESCA,KIRP,LUAD,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000167595 | PROSER3 | BRCA,CHOL,KIRP,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000174943 | KCTD13 | BRCA,CHOL,ESCA,KIRP,LUAD | BRCA,CHOL,KIRP | | ENSG00000260852 | ENSG00000187535 | IFT140 | BRCA,CHOL,KIRP,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000198707 | CEP290 | BRCA,CHOL,KIRP,LAML,PRAD | CHOL | | ENSG00000260852 | ENSG00000110844 | PRPF40B | CHOL,KIRP,LUAD,OV,UCS | CHOL | | ENSG00000260852 | ENSG00000119772 | DNMT3A | CHOL,KIRP,LUAD,OV,PRAD,UCS | CHOL | | ENSG00000260852 | ENSG00000144134 | RABL2A | CHOL,KIRP,LAML,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000163257 | DCAF16 | CHOL,KIRP,LAML,OV,PRAD | CHOL | | ENSG00000260852 | ENSG00000172534 | HCFC1 | CHOL,LAML,OV,PRAD,UCS | CHOL | |
LncRNA-TF complex positively regulates the gene expression by target promoter region (#cancer types with positive correlation >= 5). |
lncRNA ID | TF ID | TF Name | PCgene ID | PCgene Name | Number of Cancer | Canaer Types |
LncRNA-TF complex negatively regulates the gene expression by target promoter region (#cancer types with negative correlation >= 5). |
lncRNA ID | TF ID | TF Name | PCgene ID | PCgene Name | Number of Cancer | Canaer Types |
LncRNA-RBP complex positively regulates the exon skippping events by target skipped eoxon region. |
LncRNA Ensembl ID | RBP ID | RBP Gene Name | Exon Skipping ID | Skipped Exon | EX Gene Name | EX Affected TransID | ORF_anno | Cancer Type |
LncRNA-RBP complex negatively regulates the exon skippping events by target skipped eoxon region. |
LncRNA Ensembl ID | RBP ID | RBP Gene Name | Exon Skipping ID | Skipped Exon | EX Gene Name | EX Affected TransID | ORF_anno | Cancer Type |
lncRNA regulates differential expressed mRNA by directly targeting 3' UTR region. |
LncRNA Ensembl ID | LncRNA ENST ID | PC Gene Name | PC Gene ID | PC ENST ID | dG | nDG | Cancer with PC gene up-regulation | Cancer with PC gene Down-regulation |
lncRNA regulates mRNA by competing the miRNA binding site with mRNA. |
LncRNA Ensembl ID | lncRNA-miRNA-mRNA | Cancer Types |
ORFfinder result for the gencode.v22.lncRNA.transcript.fa. |
lncRNA Ensembl ID | lncRNA ENST ID | length(AA) | start at transcript | end at transcript | ENSG00000260852.1 | ENST00000563777.1 | 61 | 183 | 368 |
|